Abstract
While arginine deiminase (ADI) from Mycoplasma arginini is a well-known anticancer agent, very little is known about any such role of ADI from other bacteria. Additionally, M. arginini ADI is believed to exert its anticancer activity due to depletion of arginine from cancer cells. In this report, we demonstrate anticancer activity of ADI from Pseudomonas aeruginosa. We have also cloned and expressed a truncated form from the P. aeruginosa ADI which harbors a caspase recruitment domain (CARD). This polypeptide, called Pa-CARD, demonstrates anticancer activity without exhibiting any ADI enzymatic activity by inducing apoptosis in cancer cells but not in normal cells. Microarray experiments suggest that Pa-CARD modulates NF-kB signaling pathway genes to exert its anticancer activity.
Keywords: Arginine deiminase (ADI), Azurin, Pseudomonas aeruginosa, CARD domain, Anticancer agents
Letters in Drug Design & Discovery
Title: The Anticancer Activity of the N-Terminal CARD-Like Domain of Arginine Deiminase (ADI) from Pseudomonas aeruginosa
Volume: 6 Issue: 6
Author(s): Madhuchhanda Kundu, Johnson Thomas, Arsenio M. Fialho, Jennifer M. Kwan, Leonilde M. Moreira, Magdy Mahfouz, Tapas K. Das Gupta and Ananda M. Chakrabarty
Affiliation:
Keywords: Arginine deiminase (ADI), Azurin, Pseudomonas aeruginosa, CARD domain, Anticancer agents
Abstract: While arginine deiminase (ADI) from Mycoplasma arginini is a well-known anticancer agent, very little is known about any such role of ADI from other bacteria. Additionally, M. arginini ADI is believed to exert its anticancer activity due to depletion of arginine from cancer cells. In this report, we demonstrate anticancer activity of ADI from Pseudomonas aeruginosa. We have also cloned and expressed a truncated form from the P. aeruginosa ADI which harbors a caspase recruitment domain (CARD). This polypeptide, called Pa-CARD, demonstrates anticancer activity without exhibiting any ADI enzymatic activity by inducing apoptosis in cancer cells but not in normal cells. Microarray experiments suggest that Pa-CARD modulates NF-kB signaling pathway genes to exert its anticancer activity.
Export Options
About this article
Cite this article as:
Kundu Madhuchhanda, Thomas Johnson, Fialho M. Arsenio, Kwan M. Jennifer, Moreira M. Leonilde, Mahfouz Magdy, Das Gupta K. Tapas and Chakrabarty M. Ananda, The Anticancer Activity of the N-Terminal CARD-Like Domain of Arginine Deiminase (ADI) from Pseudomonas aeruginosa, Letters in Drug Design & Discovery 2009; 6 (6) . https://dx.doi.org/10.2174/157018009789057580
DOI https://dx.doi.org/10.2174/157018009789057580 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Biomarker Diversity, Validation and Clinical Translation: Tenets for Emergent Personalized Medicine Initiatives
Current Pharmacogenomics and Personalized Medicine Use of Recombinant Human Erythropoietin as an Antianemic and Performance Enhancing Drug
Current Pharmaceutical Biotechnology Mechanisms of Drug Resistance to Vascular Endothelial Growth Factor (VEGF) Inhibitors
Anti-Cancer Agents in Medicinal Chemistry New Analytical Tools for Studying Autoimmune Diseases
Current Pharmaceutical Design Porphyrins as Radiosensitizing Agents for Solid Neoplasms
Current Pharmaceutical Design Overview of Prostate Biomarkers as Potential Targets for Immunotherapy
Current Cancer Therapy Reviews Cancer Imaging Agents for Positron Emission Tomography: Beyond FDG
Current Medical Imaging Dysregulated Post-Transcriptional Control of COX-2 Gene Expression in Cancer
Current Pharmaceutical Design Thiosemicarbazones as Potent Anticancer Agents and their Modes of Action
Mini-Reviews in Medicinal Chemistry Recent Progress of Small Molecular VEGFR Inhibitors as Anticancer Agents
Mini-Reviews in Medicinal Chemistry Tumor Specific Imaging Using Tc-99m and Ga-68 Labeled Radiopharmaceuticals
Current Medical Imaging Recent Advances in Small Molecule Prodrugs for Cancer Therapy
Anti-Cancer Agents in Medicinal Chemistry Cancer and Phase II Drug-Metabolizing Enzymes
Current Drug Metabolism Genetic Predisposition to Neonatal Tumors
Current Pediatric Reviews Epigenetic Regulation of Genes Encoding Drug-Metabolizing Enzymes and Transporters; DNA Methylation and Other Mechanisms
Current Drug Metabolism Radiolabeled Probes Targeting G-Protein-Coupled Receptors for Personalized Medicine
Current Pharmaceutical Design Molecular Biomarkers for Lung Adenocarcinoma: A Short Review
Current Cancer Therapy Reviews Targeting Dopaminergic System for Treating Nicotine Dependence
Central Nervous System Agents in Medicinal Chemistry A Closer Look at α-Secretase
Current Alzheimer Research The Role of Heat Shock Proteins in Cisplatin Resistance
Anti-Cancer Agents in Medicinal Chemistry